[PDF] Top 20 Etiology of hyperparathyroidism and bone disease during chronic hemodialysis: II Factors affecting serum immunoreactive parathyroid hormone
Has 10000 "Etiology of hyperparathyroidism and bone disease during chronic hemodialysis: II Factors affecting serum immunoreactive parathyroid hormone" found on our website. Below are the top 20 most common "Etiology of hyperparathyroidism and bone disease during chronic hemodialysis: II Factors affecting serum immunoreactive parathyroid hormone".
Etiology of hyperparathyroidism and bone disease during chronic hemodialysis: II Factors affecting serum immunoreactive parathyroid hormone
... examine the independent effects of perturbation of each of these factors. It was observed that plasma concentration of IPTH was lowest with the combination of high dialysate calcium and low plasma phosphate, ... See full document
8
Etiology of Hyperparathyroidism and Bone Disease during Chronic Hemodialysis III EVALUATION OF PARATHYROID SUPPRESSIBILITY
... with chronic renal insufficiency being treated by long-term ...two immunoreactive species of parathyroid hormone in plasma (iPTH-9, mol wt 9500; iPTH-7, mol wt 7000) were estimated by ... See full document
9
Etiology of hyperparathyroidism and bone disease during chronic hemodialysis: I Association of bone disease with potentially etiologic factors
... kidney disease was almost 2 yr longer in the patients without bone disease than in those with bone ...the hemodialysis was performed and to the calcium concentration in the dialysate ... See full document
8
Hypo-Hyperparathyroidism: Evidence for a Defective Parathyroid Hormone
... With serum calcium and phosphorus levels normal, ethy- lenediaminetetraacetic acid infusion was followed by an increase in plasma parathyroid hormone level but not in urinary cyclic aden[r] ... See full document
8
Is serum phosphorus control related to parathyroid hormone control in dialysis patients with secondary hyperparathyroidism?
... elevated serum parathyroid hormone (PTH), phos- phorus and calcium have all been linked with increased morbidity and mortality in dialysis (CKD stage 5D) patients [3-7], the National Kidney ... See full document
11
Relationship between parathyroid hormone and serum creatinine levels in chronic kidney disease patients
... The parathyroid glands are four pea-sized glands located on the thyroid gland in the ...and parathyroid glands produce distinct hormones with specific ...The parathyroid glands secrete ... See full document
5
Intraoperative parathyroid hormone (PTH) testing in patients with primary hyperparathyroidism and PTH levels in the normal range
... normocalcemic hyperparathyroidism is well recog- nized in PHP, less is known about patients with high cal- cium but normal iPTH possibly leading to diagnostic difficulties [1, 3, 9, 10, 12 – ...1987, ... See full document
6
Fibroblast growth factor 23, mineral metabolism and mortality among elderly men (Swedish MrOs)
... Its serum levels are associated with mortality in dialysis patients, persons with chronic kidney disease (CKD) and prevalent cardiovascular disease (CVD), and it is associated with ... See full document
10
Risk Factors of Parathyroid Dysfunction in Elderly Patients with Chronic Kidney Disease Undergoing Hemodialysis
... of bone disease: low conversion type, high conversion type and hybridism ...Adynamic bone disease (ABD) belongs to the low conversion type, wherein the level of iPTH is low- er than ... See full document
6
Parathyroid Hormone in Human Plasma: IMMUNOCHEMICAL CHARACTERIZATION AND BIOLOGICAL IMPLICATIONS
... anti-bovine parathyroid hormone antisera was characterized by their reactivity with bovine hormonal fragments (1-34, 1-13, 14-34, 19-34, 53-84) and human hormone extracted from parathyroid ... See full document
11
Neonatal Hyperparathyroidism: The Natural Course in the Absence of Surgical Intervention
... tients with neonatal hyperparathyroidism and fa- milial hypocalciuric hypercalcemia demonstrate that the concentration of calcium needed to sup- press secretion of parathyroid hormone is[r] ... See full document
6
Applicability of fibroblast growth factor 23 for evaluation of risk of vertebral fracture and chronic kidney disease-mineral bone disease in elderly chronic kidney disease patients
... which was approved by the Ethics Committee of Tokyo Kyosai Hospital. Patients were eligible for inclusion in the sample for this study when they were at least 60 years of age as of October 1st, 2010, diagnosed as having ... See full document
8
The life cycle of chondrocytes in the developing skeleton
... During skeletogenesis in the developing limb bud, chon- droprogenitor cells initiate their differentiation while neigh- boring cells undergo apoptosis, thus defining the boundaries of the developing skeletal ... See full document
13
ANAESTHETIC MANAGEMENT OF PRIMARY HYPERPARATHYROIDISM WITH RARE PRESENTATION OF MULTIPLE BROWN’S TUMOUR
... Tertiary hyperparathyroidism 1 is due to deficient response to parathyroid hormone at the level of receptor in kidney (renal resistance) in long standing cases of hyperparathyroidism and CRF ... See full document
5
Osteomalacia and Hyperparathyroid Bone Disease in Patients with Nephrotic Syndrome
... with bone disease, we studied six patients with nephrotic syndrome and normal renal ...ml/min; serum albumin, ...of immunoreactive parathyroid hormone were measured, and ... See full document
8
Evidence for Secondary Hyperparathyroidism in Idiopathic Hypercalciuria
... of immunoreactive parathyroid hormone (PTH) were measured in 40 patients with idiopathic hypercalciuria (IH) before and during reversal of hypercalciuria with thiazide, and in four normal ... See full document
10
Rapid regression of calciphylaxis in a hemodialysis patient after intensive management of disturbance of calcium and phosphate metabolism: a case report with literature review
... risk factors for calciphylaxis include renal insufficiency, obesity, therapy with vitamin K antago- nists, calcium-based phosphate binders, vitamin D re- ceptor activators (VDRA) and corticosteroids, secondary ... See full document
8
Relationship between parathyroid mass and parathyroid hormone level in hemodialysis patients with secondary hyperparathyroidism
... secondary hyperparathyroidism, mineral abnormal- ities, and increased risk of cardiovascular disease [16, ...secondary hyperparathyroidism leads to nodular trans- formation of the parathyroids in up ... See full document
7
Decrease in serum immunoreactive parathyroid hormone in rats and in parathyroid hormone secretion in vitro by 1,25 dihydroxycholecalciferol
... dihydroxycholecalciferol used for most experiments was 1nM, which is in the range found in rat serum. 1,25-Dihydroxycholecalciferol at 1 or 100 nM significantly inhibited parathyroid hormone ... See full document
12
Reversal of Secondary Hyperparathyroidism by Cimetidine in Chronically Uremic Dogs
... Calcium balance was negative in all seven dogs before cimetidine (−347±84 mg/72 h) and remained so in the control dogs; it became positive in the five treated dogs after 12 wk (1,141±409 mg/72 h) (P < 0.05). ... See full document
9
Related subjects